Low Testosterone Symptoms: Complete Self-Check Before You Pay for Labs

What are the symptoms of low testosterone?

Low testosterone symptoms cluster in three domains: sexual (low libido, fewer morning erections, erectile dysfunction), physical (fatigue, lost muscle and gained fat despite stable training and diet, hot flushes, breast tenderness, body hair changes, low-trauma fractures), and cognitive-emotional (low mood, irritability, brain fog, motivation drop). The Endocrine Society 2018 clinical practice guideline (Bhasin et al., JCEM, DOI 10.1210/jc.2018-00229) treats sexual symptoms and a handful of physical features (gynecomastia, body hair loss, low-trauma fracture, height loss, hot flushes) as the most specific markers; fatigue, mood changes, and concentration problems are common but non-specific.

That distinction is the entire point of this self-check. Symptoms alone cannot diagnose low testosterone — sleep apnea, depression, hypothyroidism, anemia, and chronic alcohol use produce the same symptom cluster. A structured symptom inventory tells you whether labs are worth ordering. Two morning total testosterone draws on separate days, both below the lab reference range, are what actually establish the diagnosis per the Endocrine Society and AUA.

For the lab schedule itself, see the TRT blood work schedule. For self-pay testing options, see our review of the best at-home testosterone test kits.

Why a structured self-check matters before you pay for labs

A complete pre-TRT lab panel — total and free testosterone, SHBG, LH, FSH, sensitive estradiol, prolactin, CBC, CMP, lipids, A1C, PSA, TSH — runs $200-450 self-pay at most retail labs. If you walk in with a vague sense of feeling off, the panel may come back clean and you have learned that something else is driving symptoms. A structured self-check before the draw does three things.

• It separates specific from non-specific symptoms. A 36-year-old with low libido, fewer morning erections, and shrinking testicles is presenting a different picture than a 36-year-old with fatigue and brain fog. The first profile points squarely at the HPG axis; the second has a long differential that includes sleep, thyroid, and mood disorders.
• It surfaces confounders. If you snore loudly, wake unrefreshed, and your partner reports observed apneas, a sleep study likely matters more than a testosterone panel — and untreated sleep apnea suppresses morning testosterone independent of any HPG axis disease.
• It gives the clinician a usable history. A symptom inventory with onset, duration, and severity beats “I just don't feel right” by a wide margin. It also makes the labs interpretable when they come back.

The diagnostic standard, in plain language

Both the Endocrine Society 2018 guideline and the AUA 2018 testosterone deficiency guideline (Mulhall et al., updated 2024) require two things to diagnose hypogonadism: consistent signs or symptoms of androgen deficiency, plus two morning total testosterone measurements drawn on separate days that are both below the lab's lower reference limit (commonly around 264 ng/dL per Travison et al., JCEM 2017 harmonized reference). One low value is not enough. Symptoms without low labs is not enough. The clinical picture and the biochemistry both have to line up.

The ADAM questionnaire (10 questions)

The Androgen Deficiency in the Aging Male (ADAM) questionnaire was developed by John Morley and colleagues at Saint Louis University and published in Metabolism in 2000 (PMID 10859292). It is the most widely used symptom screen for low testosterone and gives you a yes/no result you can take to a clinician.

The 10 ADAM questions

1. Do you have a decrease in libido (sex drive)?
2. Do you have a lack of energy?
3. Do you have a decrease in strength and/or endurance?
4. Have you lost height?
5. Have you noticed a decreased “enjoyment of life”?
6. Are you sad and/or grumpy?
7. Are your erections less strong?
8. Have you noticed a recent deterioration in your ability to play sports?
9. Are you falling asleep after dinner?
10. Has there been a recent deterioration in your work performance?

How to score it

A “positive” ADAM screen requires a yes to question 1 (libido) or question 7 (erections), or yes to any three of the other questions. The original validation reported sensitivity of about 88 percent — meaning ADAM catches most men with biochemical hypogonadism — but specificity around 60 percent, meaning a meaningful share of positives turn out to have normal testosterone on labs.

The Endocrine Society guideline does not recommend ADAM as a population screening tool for that reason. As a personal symptom inventory before you pay for a panel, it is useful. As a diagnosis, it is not.

The AMS questionnaire (17 questions)

The Aging Males' Symptoms (AMS) scale was developed by Lothar Heinemann and colleagues and published in Health and Quality of Life Outcomes in 2003 (PMID 14687368). Where ADAM gives a yes/no answer, AMS measures severity across 17 items on a five-point scale (1 = none, 5 = extremely severe). It produces a total score plus three subscale scores — psychological, somatovegetative, and sexual.

What AMS captures

Each item is scored 1-5. The 17 items cluster into three domains.

• Somatovegetative (physical): Decline in general well-being, joint and muscle aches, excessive sweating, sleep problems, increased need for sleep / often tired, irritability, nervousness, anxiety.
• Psychological: Depressive mood, feeling burnt out / having hit rock bottom, sense that life's peak is past, feeling that nothing makes sense.
• Sexual: Decrease in beard growth, decreased ability or frequency to perform sexually, decrease in number of morning erections, decreased sexual desire / libido, “exhaustion” in men.

How to interpret your AMS score

Total scores published in the original validation translate roughly as: 17-26 = no or minimal complaints; 27-36 = mild; 37-49 = moderate; 50 or above = severe. The strength of AMS is severity tracking — your score before any intervention compared to your score 12 weeks later is a useful signal whether something is changing. The weakness is the same as ADAM's: psychological and somatovegetative subscale scores correlate poorly with serum testosterone in many studies, so a high AMS does not mean low T.

Most TRT prescribers use AMS or a similar instrument as a longitudinal tool — administered at baseline, again at 3 months, then at 6 and 12 months. Outside of a clinical relationship, AMS is most useful for organizing your own thinking about which symptoms are bothering you most.

Hormone-specific symptoms by domain

Beyond questionnaire scores, the Endocrine Society guideline groups testosterone-related symptoms by how specific they are to androgen deficiency. The more specific the symptom, the more weight a low lab value carries when symptoms and biochemistry align.

Sexual symptoms (most specific)

• Low libido — reduced spontaneous sexual interest, not just performance-related.
• Fewer morning erections — the “number per week” metric. A drop from most mornings to occasional or none over months is meaningful.
• Reduced spontaneous erections — distinct from situational ED, which has a longer differential.
• Decreased ejaculate volume — less specific but commonly reported.
• Delayed time to orgasm — reported in some men but heavily confounded by SSRIs and other medications.

Physical symptoms (mixed specificity)

• Loss of muscle mass and strength — particularly when training and protein intake are stable. Body composition shift toward central adiposity is common.
• Hot flushes — uncommon but highly specific when present in a man without recent androgen deprivation therapy.
• Gynecomastia or breast tenderness — points to elevated estradiol, often in the context of low testosterone-to-estradiol ratio.
• Loss of body or pubic hair — specific but slow to develop.
• Shrinking testicular volume — measured at clinical exam, suggests primary testicular failure or longstanding suppression.
• Low-trauma fractures or height loss — testosterone deficiency is a recognized contributor to male osteoporosis. The Endocrine Society 2018 guideline lists low-trauma fracture as a feature warranting evaluation.
• Fatigue — common, non-specific, heavily confounded by sleep, thyroid, anemia, and depression.

Cognitive and emotional symptoms (least specific)

• Depressed mood — overlaps almost completely with major depressive disorder.
• Irritability — non-specific.
• Reduced motivation or drive — overlaps with depression and burnout.
• Brain fog and reduced concentration — common but the differential includes sleep deprivation, medication effects, anxiety, and ADHD.
• Sleep disturbance — bidirectional with testosterone; poor sleep suppresses morning T, low T can disrupt sleep architecture.

The pattern that most strongly suggests genuine hypogonadism is several specific sexual symptoms (low libido, fewer morning erections, reduced spontaneous erections) plus at least one specific physical sign (hot flushes, gynecomastia, body hair loss, shrinking testicles, low-trauma fracture). Fatigue and brain fog without the sexual cluster usually has a different driver.

Symptom severity at a glance

Conditions that mimic low testosterone symptoms

Most men who walk into a clinic asking about TRT have at least one condition on the list below contributing to their symptoms. Many have more than one. The Endocrine Society 2018 guideline explicitly recommends evaluating and addressing these before attributing symptoms to low testosterone.

The high-overlap differential

• Obstructive sleep apnea (OSA). Untreated OSA fragments sleep, suppresses morning testosterone, and produces fatigue, low libido, mood changes, and cognitive complaints. STOP-BANG screening (snore, tired, observed apnea, BP, BMI, age, neck, gender) flags risk; diagnosis requires a sleep study. Treating OSA can raise morning testosterone in some men without any TRT.
• Major depressive disorder. Anhedonia, low energy, low libido, sleep disturbance, and concentration problems are core MDD criteria. The PHQ-9 takes two minutes and is the standard screen.
• Primary hypothyroidism. Fatigue, weight gain, cold intolerance, constipation, and cognitive slowing overlap with low T symptoms. TSH belongs on every pre-TRT panel for this reason.
• Anemia. CBC catches it. Iron deficiency in men always warrants GI workup.
• Chronic alcohol use. Suppresses LH and testicular testosterone production, drives weight gain, disrupts sleep, and elevates SHBG over time.
• Opioid use. Chronic opioid therapy is one of the most common causes of secondary hypogonadism in men. The mechanism is hypothalamic suppression of GnRH.
• Uncontrolled type 2 diabetes and metabolic syndrome. Obesity drives aromatization of testosterone to estradiol and lowers SHBG; insulin resistance further depresses total testosterone. Weight loss and improved glycemic control raise testosterone in many men.
• Vitamin D deficiency. Common, easy to test, easy to fix. Some observational data link low 25-OH vitamin D to lower testosterone, though intervention trials are mixed.
• Chronic sleep restriction. Even without OSA, sleeping under 6 hours per night meaningfully lowers morning testosterone in healthy young men.
• Medications. Glucocorticoids, SSRIs (libido and orgasm effects), spironolactone, ketoconazole, and finasteride can all influence sexual function and / or testosterone biology.

A short example

A 42-year-old man with BMI 33, loud snoring, daytime fatigue, low libido, and a stressful job has at least four plausible drivers: obesity-driven hypogonadism, sleep apnea, chronic stress affecting sleep, and possibly mood. A pre-TRT lab panel without a sleep study and without addressing weight is incomplete. If labs return total testosterone of 320 ng/dL on a single morning draw, that does not yet meet diagnostic criteria — and starting TRT before a sleep study would mask whichever driver is dominant.

Red-flag symptoms that demand labs now (not a self-check)

Some presentations are not appropriate for at-home symptom inventories. They warrant prompt clinician evaluation because the underlying conditions can be more serious than uncomplicated hypogonadism.

1. Sudden loss of libido or erectile function over weeks. An acute change in a previously healthy man can suggest a pituitary lesion, severe stress reaction, or vascular cause.
2. Vision changes or persistent severe headaches. Bitemporal vision loss with low testosterone, low LH, and low FSH suggests a pituitary mass — typically a non-functioning adenoma or, less commonly, a prolactinoma. This needs imaging, not a TRT consult.
3. Galactorrhea (any nipple discharge in a man). Suggests hyperprolactinemia, which warrants prolactin testing and pituitary MRI if elevated.
4. Breast lump. Distinct from gynecomastia. A discrete lump in a man warrants imaging and clinical exam to rule out male breast cancer.
5. Low-trauma fracture or significant unexplained height loss. Suggests advanced osteoporosis. Bone density imaging and a workup for the cause belong here, alongside testosterone evaluation.
6. Significant unintended weight loss with severe fatigue. Always warrants broader workup — testosterone is one piece, not the whole picture.
7. Suicidal thoughts or severe depression. Mental health evaluation first, hormone workup parallel. Do not delay psychiatric care for a TRT consult.

Urologist or endocrinologist — who to see

Either is a reasonable first stop after a primary care evaluation. The right choice depends on what the workup is pointing toward.

When a urologist makes more sense

• Primary complaint is sexual — erectile dysfunction, libido loss, ejaculatory issues
• Abnormal PSA or prostate exam findings
• Concurrent infertility evaluation
• Suspected primary testicular failure (high LH and FSH with low T) of any cause
• Active interest in TRT with no pituitary or prolactin abnormality

When an endocrinologist makes more sense

• Low LH and FSH alongside low total testosterone (suggests secondary / hypothalamic-pituitary cause)
• Elevated prolactin on screening
• Concurrent thyroid disease or suspected pituitary disease
• Men under 40 with very low testosterone of unclear cause
• Complex metabolic context — uncontrolled diabetes, suspected Cushing's, growth hormone questions
• Family history of pituitary or hypothalamic conditions

The 2018 AUA testosterone deficiency guideline (Mulhall et al., updated 2024) is the urology-side reference. The 2018 Endocrine Society guideline (Bhasin et al., DOI 10.1210/jc.2018-00229) is the endocrinology-side reference. The two documents agree on the diagnostic threshold and most monitoring details. If you bring either one to your appointment, you will be working from the same playbook your clinician is.

Why symptoms alone are not a diagnosis

Several large studies have shown weak correlation between symptom scores and serum testosterone. The European Male Aging Study (Wu FC et al., NEJM 2010) defined late-onset hypogonadism as requiring three sexual symptoms (low libido, fewer morning erections, ED) plus total testosterone below approximately 320 ng/dL — and even that conservative definition captured only about 2 percent of men aged 40-79 in the cohort. Most men with symptoms had normal testosterone. Most men with low testosterone by single-draw definitions were asymptomatic.

That mismatch is exactly why both major guidelines require both clinical features and confirmed biochemical low testosterone. Diagnosing hypogonadism by symptoms alone overdiagnoses; diagnosing by a single low value alone overdiagnoses; pairing them is what works.

If your symptom self-check looks like genuine hypogonadism — multiple specific sexual symptoms, a physical sign or two, no obvious sleep or mood confounder — the next step is a complete pre-TRT lab panel. See the TRT blood work schedule for which markers to order and the morning-draw protocol. If cost is the issue, our review of the best at-home testosterone test kits covers self-pay options.

If labs come back showing low testosterone and your clinician is mapping out treatment options, comparing approaches is the next read. Start with enclomiphene vs TRT if fertility preservation matters, or TRT before and after for a realistic timeline of what changes on therapy.

The bottom line

Low testosterone symptoms are real, but they are also non-specific. The most useful self-check before paying for labs is structured: run through the ADAM and AMS questionnaires, separate specific symptoms (libido, morning erections, hot flushes, gynecomastia, body hair changes, low-trauma fracture) from non-specific ones (fatigue, mood, brain fog), and honestly inventory the confounders — sleep, mood, alcohol, opioids, weight, thyroid.

Three rules keep the workup pointed in the right direction. First, treat positive ADAM or high AMS as a signal to test, not as a diagnosis. Second, address obvious confounders before ordering hormone panels — a sleep study and a PHQ-9 are cheap, fast, and frequently change the answer. Third, when you do test, do it right: two morning total testosterone draws on separate days, plus the supporting markers (free T, SHBG, LH, FSH, sensitive estradiol, prolactin) that tell the clinician where the problem is.

For the next reads on what comes after a positive symptom screen, see the TRT blood work schedule, our review of at-home testosterone test kits, and the enclomiphene vs TRT comparison if fertility preservation is a priority. For a realistic look at what therapy actually feels like over time, see TRT before and after.